Drug intelligence / Profile preview

C-MB-P lock solution

Development stage
Unknown
Lead developer
CorMedix
Modality
Small Molecules
Administration
Intracatheter
01

Overview

C-MB-P lock solution is a multicomponent catheter lock formulation designed to prevent catheter-related bloodstream infections and maintain catheter patency in patients with indwelling central venous catheters, particularly those undergoing hemodialysis. The solution contains 7% sodium citrate (0.24 M), 0.15% methylene blue, 0.15% methylparaben, and 0.015% propylparaben as active ingredients[1][2][5]. It acts as both an antimicrobial and antithrombotic agent by killing planktonic and sessile microorganisms (including bacteria in biofilms) within one hour of exposure while also preventing clot formation[1][2]. Clinical studies have shown that the C-MB-P lock solution significantly reduces the risk of catheter-related bloodstream infection compared to heparin-based locks and provides comparable protection against loss of patency due to thrombosis[2][3]. The mechanism involves chelation by citrate for anticoagulation, direct antimicrobial activity from methylene blue and parabens, and broad-spectrum efficacy without promoting microbial resistance over repeated exposures[1][8].

Brand names
C-MB-P
Other names
citrate-methylene blue-parabens lock solutionsodium citrate-parabens-methylene blue lock solution
02

Targets

Bacterial and fungal cell membrane lipid bilayer

Beyond the preview

Go deeper on C-MB-P lock solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-MB-P lock solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call